Breast cancer metastases are molecularly distinct from their primary tumors

Oncogene

Volumn 27, Issue 15, 2008, Pages 2148-2158

  Vecchi, M ^a   Confalonieri, S ^a   Nuciforo, P ^a   Vigano M A ^a,c   Capra, M ^a   Bianchi, M ^a   Nicosia, D ^a   Bianchi, F ^a   Galimberti, V ^b   Viale, G ^b,c   Palermo, G ^d   Riccardi, A ^d   Campanini, R ^d   Daidone, M G ^e   Pierotti, M A ^a,e   Pece, S ^b,c   Di Fiore, P P ^a,b,c  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Breast cancer; Gene profiling; Metastases

Indexed keywords

ARTICLE; BREAST CANCER; BREAST METASTASIS; BREAST TUMOR; CELL MOTILITY; COHORT ANALYSIS; DISEASE COURSE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC ENGINEERING; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TISSUE MICROARRAY;

ADULT; AGED; ALGORITHMS; BREAST NEOPLASMS; CELL MOVEMENT; CLUSTER ANALYSIS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MATCHED-PAIR ANALYSIS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SERPINS;

EID: 41649098379     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210858     Document Type: Article

References (41)

1. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H et al. (2004). Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32.
2. Beltran A, Parikh S, Liu Y, Cuevas BD, Johnson GL, Futscher BW et al. (2007). Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors. Oncogene 26: 2791-2798.
3. Bezault J, Bhimani R, Wiprovnick J, Furmanski P. (1994). Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 54: 2310-2312.
4. Capra M, Nuciforo PG, Confalonieri S, Quarto M, Bianchi M, Nebuloni M et al. (2006). Frequent alterations in the expression of serine/threonine kinases in human cancers. Cancer Res 66: 8147-8154.
5. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC et al. (2004). Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351: 2159-2169.
6. Eberwine J, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R et al. (1992). Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA 89: 3010-3014.
7. Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao C et al. (2007). Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res Treat 103: 319-329.
8. Fidler IJ, Kripke ML. (1977). Metastasis results from preexisting variant cells within a malignant tumor. Science 197: 893-895.
9. Gangnus R, Langer S, Breit E, Pantel K, Speicher MR. (2004). Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients. Clin Cancer Res 10: 3457-3464.
10. Gupta GP, Massague J. (2006). Cancer metastasis: building a framework. Cell 127: 679-695.
11. Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C et al. (2007). Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446: 765-770.
12. Hao X, Sun B, Hu L, Lahdesmaki H, Dunmire V, Feng Y et al. (2004). Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 100: 1110-1122.
13. Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H et al. (2002). MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2: 289-300.
14. Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J et al. (2006). Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 66: 10292-10301.
15. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C et al. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549.
16. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S et al. (1998). Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847.
17. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L et al. (2004). Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 101: 4966-4971.
18. Lamelas ML, Vazquez J, Enguita MI, Rodriguez JC, Gonzalez LO, Merino AM et al. (2000). Apolipoprotein D expression in metastasic lymph nodes of breast cancer. Int J Surg Invest 2: 285-293.
19. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL et al. (2007). Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446: 690-694.
20. Minn AJ, Gupta GP, Padua D, Bos P, Nguyen DX, Nuyten D et al. (2007). Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci USA 104: 6740-6745.
21. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al. (2005a). Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524.
22. Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M et al. (2005b). Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115: 44-55.
23. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
24. Nguyen DX, Massague J. (2007). Genetic determinants of cancer metastasis. Nat Rev Genet 8: 341-352.
25. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. (2000). Molecular portraits of human breast tumours. Nature 406: 747-752.
26. Ramaswamy S, Ross KN, Lander ES, Golub TR. (2003). A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54.
27. Reddy KB, McGowen R, Schuger L, Visscher D, Sheng S. (2001). Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model. Oncogene 20: 6538-6543.
28. Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B. (2003). Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci USA 100: 9482-9487.
29. Schedin P, Elias A. (2004). Multistep tumorigenesis and the microenvironment. Breast Cancer Res 6: 93-101.
30. Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ et al. (2003). From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 100: 7737-7742.
31. Shi HY, Zhang W, Liang R, Abraham S, Kittrell FS, Medina D et al. (2001). Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res 61: 6945-6951.
32. Suzuki M, Tarin D. (2007). Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications. Mol Oncol 1: 172-180.
33. Ushida Y, Sekine K, Kuhara T, Takasuka N, Iigo M, Tsuda H. (1998). Inhibitory effects of bovine lactoferrin on intestinal polyposis in the Apc(Min) mouse. Cancer Lett 134: 141-145.
34. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
35. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
36. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F et al. (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
37. Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van't Veer LJ. (2003). Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 100: 15901-15905.
38. Weigelt B, Wessels LF, Bosma AJ, Glas AM, Nuyten DS, He YD et al. (2005). No common denominator for breast cancer lymph node metastasis. Br J Cancer 93: 924-932.
39. Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M et al. (2002). Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2: 485-495.
40. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C et al. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
41. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S et al. (1994). Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526-529.